‘The research paves the way for cell therapies to treat liver disease – in other words, growing ‘mini-bile ducts’ in the lab as replacement parts that can be used to […]

The National Prostate Cancer Audit (NPCA) has published a short report on the use of the Cambridge-developed Cambridge Prognostic Groups for non-metastatic prostate cancer and its utility and benefit in […]